Loading…
DIA Europe 2019 has ended
avatar for Peter Mol

Peter Mol

CBG-MEB (Dutch Medicines Evaluation Board)
Principal Clinical Assessor, University Medical Center Groningen; Member SAWP
Peter Mol is a principal assessor at the Dutch Medicines Evaluation Board and a member (vice chair) of EMA’s Scientific Advice Working Party. He is chair of the EMA Cross-Committee Task force on Registries. He is also an assistant professor at the University Medical Center Groningen. His research interest is in the area of regulatory science; from new tools to optimize regulatory decision-making (especially impact of personalised medicine and real world evidence), to improve knowledge transfer and with a specific interest in safety communication.